Human Metabolome Technologies, Inc. provided earnings guidance for the full year ending June 2022. For the period, the company expected net sales of JPY 1,200 million, operating profit of JPY 150 million, profit attributable to owners of parent of JPY 170 million and basic earnings per share of JPY 28.81.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
655 JPY | -1.06% | -2.38% | +2.34% |
1st Jan change | Capi. | |
---|---|---|
+2.34% | 24.61M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 6090 Stock
- News Human Metabolome Technologies, Inc.
- Human Metabolome Technologies, Inc. Provides Earnings Guidance for the Full Year Ending June 2022